14. March 2012
Effectively upscaling bioprocesses
Shortening development times is crucial in the biopharmaceutical industry. Scientists at Genmab have established a screening procedure for monoclonal antibody-producing CHO cell lines. Using a DASGIP Parallel Bioreactor System they accelerated process development gaining reliable and scalable results - as shown in the European Biotechnology News March issue.